Airborne (dietary supplement)
From Wikipedia, the free encyclopedia
Airborne is a dietary supplement containing herbal extracts, amino acids, antioxidants, electrolytes, synthetic vitamins, and other ingredients. It was created by a Victoria Knight-McDowell in the early 1990s. It is offered for sale over-the-counter in many U.S. retail stores in three different forms: tablet, chewable lozenge, or powder.
It has been accused by the FTC of using false advertising[1] in its marketing and making unproven claims[2] that it could help ward off harmful bacteria and germs and help prevent the flu and the common cold. It has therefore been the subject of class action lawsuits and settlements. In addition to previous settlements including over $23 million in early 2008, Airborne paid an additional $7 million settlement on December 16, 2008 as part of charges that it made unproven claims to cure or prevent illness.[2] There are no studies supporting Airborne's effectiveness that meet scientific standards.
Contents |
[edit] Invention and retail success
The formula for Airborne was developed by Victoria Knight-McDowell, an elementary school teacher from Carmel, California. In the early 1990s, she began brewing herbal and vitamin cocktails and selling them in tablet form to local drug stores. Knight-McDowell eventually contracted cartoonist Lloyd Dangle to create Airborne's brand and packaging. In 1997 specialty grocery chain Trader Joe's ordered 300 cases of Airborne tablets to sell, and by 1999 other larger chains, such as Wal-Mart and Rite Aid, began stocking Airborne.[citation needed]
[edit] Testing, research, and controversy
Although the manufacturer recommends that Airborne be taken "at the first sign of a cold symptom, or before entering crowded environments, like airplanes and offices," Airborne has not undergone any testing by the US Food and Drug Administration (FDA). Further, the manufacturer itself makes no actual claims with regard to user health (the claims are all along the lines of "all natural", "dissolves quickly", etc.) Because it is sold as a dietary supplement and not as a drug, current law allows it to be marketed without prior review and approval of testing results that demonstrate that it provides a medical remedy. However, all claims on the label for consumer products have to be truthful and supported by scientific evidence.
There are no studies supporting Airborne's effectiveness that meet scientific standards. The "GNG Pharmaceutical Services Inc." study often referenced in the debate over Airborne's effectiveness was sponsored by the Knight-McDowell Labs, manufacturers of Airborne.[1] In February 2006, ABC News discovered that GNG Pharmaceutical Services has no official clinic, scientists, or even doctors. In fact the company comprises only two men, who started the company just to perform this study. Because of the bad publicity that this controversy has brought forth, Knight-McDowell Labs has removed all references to the study from their packaging and web site.[3]
A medical report on Airborne addressed some of these concerns, specifically regarding its large amounts of vitamin C:
There are some concerns. First, there is no conclusive evidence that this product or any of its ingredients prevents colds or shortens their duration. Second, the adult tablet contains 1 g of vitamin C, and the directions for use advise taking 1 tablet at the first sign of a cold and repeating the dose every 3 hours as necessary. Vitamin C in doses higher than 1 g increases oxalate and urate excretion and may cause kidney stones.[4] Third, the safety of this herbal extraction combination has not been established. And with herbs and dietary supplements in general, we only have the manufacturers’ word on the label for what’s in them.[5]
[edit] Class action lawsuits and settlements
A class action lawsuit was filed against Airborne Health, Inc. (and other defendants) alleging that Airborne falsely advertised certain therapeutic properties, including the ability to cure or prevent the common cold, when marketing products under the Airborne brand name. Defendants denied any wrongdoing or illegal conduct but have agreed to settle the litigation.[6]
The Center for Science in the Public Interest (CSPI) participated in the class action lawsuit against Airborne. Their senior nutritionist had this to say:
- "There's no credible evidence that what's in Airborne can prevent colds or protect you from a germy environment," said CSPI senior nutritionist David Schardt, who reviewed Airborne's claims. "Airborne is basically an overpriced, run-of-the-mill vitamin pill that's been cleverly, but deceptively, marketed."[7]
On March 4, 2008, Airborne Health Inc. agreed to pay $23.3 million to settle the lawsuit.[8] Customers with proof of purchase will be refunded for any Airborne they have ever bought. Those without proof of purchases will be reimbursed for up to six packages. Any claims must have been postmarked or received prior to September 15, 2008 in order to be considered "timely".[9]
On August 14, 2008, a press release from the Federal Trade Commission (FTC) stated that Airborne Health, Inc. has agreed to pay up to $30 million to settle FTC charges. According to the FTC’s complaint:
- "there is no competent and reliable scientific evidence to support the claims made by the defendants that Airborne tablets can prevent or reduce the risk of colds, sickness, or infection; protect against or help fight germs; reduce the severity or duration of a cold; and protect against colds, sickness, or infection in crowded places such as airplanes, offices, or schools."
The FTC complaint also states that the company's founders, Victoria Knight-McDowell and Thomas John McDowell "made false claims that Airborne products are clinically proven to treat colds."[1]
[edit] Post settlement
Shortly after the settlements, a new management team was brought in to run the company. This management team was lead by Marti Morfitt, former CEO and director of CNS, Inc. In October 2009, Airborne was purchased by GF Capital Management and Advisors, LLC – a New York City-based private equity firm. GF Capital said that the entire management team, including CEO Marti Morfitt, will remain intact.[10]
[edit] References
- ^ a b Makers of Airborne Settle FTC Charges of Deceptive Advertising; Agreement Brings Total Settlement Funds to $30 Million For release August 14, 2008
- ^ a b Airborne paid an additional $7 million settlement
- ^ "Does Airborne Really Stave off Colds?". http://abcnews.go.com/GMA/Health/story?id=1664514&page=1&CMP=OTC-RSSFeeds0312. Retrieved April 4 2006.
- ^ J Am Soc Nephrol 15: 3225. 2004.
- ^ "The Medical Letter on Drugs and Therapeutics, Issue 1199" (PDF). On the effects of Airborne. The Medical Letter. http://medicalletter.org/restricted/w1199.pdf. Retrieved January 23 2006.
- ^ "Airborne Settlement". http://www.airbornehealthsettlement.com/. Retrieved 2008-03-06.
- ^ CSPI participates in class action against the makers of Airborne. Nutraceuticals World, April, 2008,
- ^ "Airborne settles lawsuit for $23.3 million". CNN. 2008-03-04. http://money.cnn.com/2008/03/04/news/companies/airborne_settlement/?postversion=2008030413. Retrieved 2008-03-04.
- ^ "DAVID WILSON VS. AIRBORNE HEALTH, INC., ET AL." (PDF). http://www.airbornehealthsettlement.com/docs/claim%20form.pdf. Retrieved 2008-03-06.
- ^ "Airborne Purchased by GF Capital". Press Release (Reuters). 2009-10-12. http://www.reuters.com/article/pressRelease/idUS75820+12-Oct-2009+BW20091012. Retrieved 2009-10-12.
[edit] External links
- AirborneHealth.com Official site of Knight-McDowell Labs.
- komo1000news.com News on Airborne dated October 27, 2005.
- Airborne Baloney, Scientific American, January 2007.